Exagen eyes best day in over 2 years on upbeat 2022 sales forecast

Exagen

15/11/2022 17:16

** Exagen Inc's shares  XGN.O  rise 30.9% to $2.75 - set for
biggest daily pct gain in more than 2 years
    ** Co expects to post 2022 sales in range of $40 mln to $43
mln, above analysts' estimates of $38.1 mln - Refinitiv IBES
data   
    ** The medical test maker also reports Q3 sales of $14.7
mln, above estimates of $9.1 mln [nGNXbJTNH4}  
    ** Including session gains, stock down ~76% YTD 
 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))